NEOGEN CHEMICALS LIMITED Fair Value
NEOGEN · Chemicals · Current price ₹2,146.4
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹270 | 4% ROE fading to 14% over ~3 yrs, on ₹309 book |
| Relative P/E | ₹568 | EPS × 52.1 peer-median P/E |
| Graham floor | ₹275 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹2,198 | Street consensus 12-month target price |
Is NEOGEN CHEMICALS LIMITED undervalued?
DocStoX estimates the fair value of NEOGEN CHEMICALS LIMITED at ₹656 per share, versus the current market price of ₹2,146. That puts the stock about -69.4% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹270), Relative P/E (₹568), Graham floor (₹275), Analyst target (₹2,198). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹270 (bear) to ₹656 (base) to ₹2,198 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on NEOGEN CHEMICALS LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.